A carregar...
Development and Validation of a Risk-Calculator for Adverse Perioperative Outcomes for Women with Ovarian Cancer
BACKGROUND: Primary cytoreduction followed by platinum based chemotherapy is the primary treatment for advanced ovarian cancer. However neoadjuvant chemotherapy followed by interval debulking is an alternative option, particularly in those who may be poor surgical candidates. OBJECTIVE: The objectiv...
Na minha lista:
| Publicado no: | Am J Obstet Gynecol |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6545148/ https://ncbi.nlm.nih.gov/pubmed/30771346 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajog.2019.02.019 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|